Brii Biosciences
Biotechnology, 1 City Center 110 Corcoran St Ofc 05-130, Durham, North Carolina, 27701, United States, 51-200 Employees
Who is BRII BIOSCIENCES
Brii Biosciences is a commercial stage biotechnology company developing therapies to address major public health challenges where patients experience high unmet medical needs, limited cho...
Read More
-
Headquarters: 1 City Center 110 Corcoran St Ofc 05-130, Durham, North Carolina, 27701, United States
-
Date Founded: 2018
-
Employees: 51-200
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
-
CEO:
Zhi Hong
Email
Phone
Industry: Biotechnology
SIC Code: 8731
|
NAICS Code: 32 |
Show More
Does something look wrong? Fix it. | View contact records from BRII BIOSCIENCES
Brii Biosciences Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Brii Biosciences
Answer: Brii Biosciences's headquarters are located at 1 City Center 110 Corcoran St Ofc 05-130, Durham, North Carolina, 27701, United States
Answer: Brii Biosciences's official website is https://briibio.com
Answer: Brii Biosciences's revenue is $10 Million to $25 Million
Answer: Brii Biosciences's SIC: 8731
Answer: Brii Biosciences's NAICS: 32
Answer: Brii Biosciences has 51-200 employees
Answer: Brii Biosciences is in Biotechnology
Answer: Brii Biosciences contact info: Phone number: Website: https://briibio.com
Answer: Brii Biosciences is a commercial stage biotechnology company developing therapies to address major public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas. With a focus on infectious diseases and central nervous system diseases, we have built a robust pipeline of potential treatment options based on patient insights and experiences, and are advancing these differentiated investigational therapies to address patient choice. Led by a visionary and experienced leadership team, Brii Bio has deep scientific expertise and a proven ability to progress therapeutic assets from discovery to commercial approval on a consolidated timeline. Established in 2018, Brii Bio now has operations in key biotech hubs, including Raleigh-Durham, the San Francisco Bay Area, Beijing and Shanghai. On July 13, 2021, the Company was officially listed on the Hong Kong Stock Exchange under the stock code 2137.HK.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
